Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
9.73
+0.37 (3.95%)
Jun 26, 2025, 4:00 PM - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $5.72 million as of June 27, 2025. Its market cap has increased by 97.34% in one year.
Market Cap
5.72M
Enterprise Value
-3.06M
1-Year Change
97.34%
Ranking
Category
Stock Price
$9.73
Market Cap Chart
Since August 1, 2016, Quoin Pharmaceuticals's market cap has decreased from $28.60M to $5.72M, a decrease of -79.99%. That is a compound annual growth rate of -16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 9.60M | 190.91% |
| Dec 31, 2024 | 3.30M | -31.25% |
| Dec 29, 2023 | 4.80M | -30.43% |
| Dec 30, 2022 | 6.90M | -54.61% |
| Dec 31, 2021 | 15.20M | 80.95% |
| Dec 31, 2020 | 8.40M | 68.00% |
| Dec 31, 2019 | 5.00M | -60.32% |
| Dec 31, 2018 | 12.60M | -66.58% |
| Dec 29, 2017 | 37.70M | 125.75% |
| Dec 30, 2016 | 16.70M | -41.61% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |